- A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. The Journal of clinical investigation. 2017 In Process GET IT
- Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity. Oncoimmunology. 2016 Academic Article GET IT
- Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1. Nature Biotechnology. 2015 Academic Article GET IT
- Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
- A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias. Blood. 2014 Academic Article GET IT
T cell receptor mimic antibodies for cancer therapy.
Times cited: 2